Sinopharm - Mask, Patient Adult (for a la carte vaccine products)
A factory audit and final random inspection and testing of finished products will be performed by a Bank nominated independent inspection agency. The inspection contract will be let by Sinopharm to the approved inspection agency with costs passed through to the Borrower to pay.
China National Pharmaceutical Group Co., Ltd. (Sinopharm) is a large healthcare group directly under the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, with 128,000 employees and a full chain in the industry covering R&D, manufacturing, logistics and distribution, retail chains, healthcare, engineering services, exhibitions and conferences, international business and financial services.
For further enquiries, please contact
Sinopharm Fortune International Trading Corp.
Address: Fortune Tower, No.4, Hui Xin Dongjie, Chao Yang District, Beijing 100029, China
Tel.: +86-10-8466 3076/ +86-13269815298
Disposable surgical patient masks, also known as medical masks, are designed to cover the nose and mouth of patients. The purpose of these masks is to limit the transmission of infectious agents from the patient to others. Surgical masks should have good breathability and internal and external faces should be clearly identified Type II or higher.
World Health Organization’s Standards:
- EN 14683 Type I or higher
- ASTM F2100 minimum level 1 or equivalent
Equivalent Standards (determined by ECRI):
- YY/T 0969
- GB/T 32610 (general)
- GBT/CTCA 7 (general)